5 reports

AXT## IS AN INVESTIGATIONAL THERAPEUTIC AGENT AND IS CURRENTLY NOT APPROVED FOR CLINICAL USE AND IS CURRENTLY BEING STUDIED FOR VARIOUS RETINAL PATHOLOGIES.

  • Hospital
  • Pathology
  • Targeted Therapy
  • Therapy
  • Australia

AXT## is an investigational therapeutic agent and is currently not approved for clinical use and is currently being studied for various retinal pathologies.

  • Hospital
  • Pathology
  • Targeted Therapy
  • Therapy
  • Australia
  • BRM-521 - DRUG PROFILE
  • 4P-004 - DRUG PROFILE

Philogen develops drugs for treatment of severe pathologies such as cancer, rheumatoid arthritis and age-related macular degeneration.

  • Arthritis
  • Pathology
  • Pharmaceutical
  • Therapy
  • Australia
  • CANAGLIFLOZIN - DRUG PROFILE

These data implicate CCR##-driven processes in the pathology of type ## diabetes and associated complications such as diabetic nephropathy.

  • Pathology
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • Australia